ID

42564

Description

A Study of Actonel for the Prevention of Bone Loss; ODM derived from: https://clinicaltrials.gov/show/NCT00452439

Link

https://clinicaltrials.gov/show/NCT00452439

Keywords

Versions (2)
  1. 10/7/16 10/7/16 -
  2. 9/2/21 9/2/21 -
Uploaded on

September 2, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Leukemia NCT00452439

English

Eligibility Leukemia NCT00452439

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00452439
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. age greater than or equal to 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. newly diagnosed all or ll receiving chemotherapy with augmented bfm, hyper-cvad or any variant of hyper-cvad.
Description

Acute lymphocytic leukemia | Lymphoid leukemia | Chemotherapy | Berlin-Frankfort-Munster protocol Increased | hyperCVAD protocol | hyperCVAD protocol Variant

Data type

boolean

Alias
UMLS CUI [1]
C0023449
UMLS CUI [2]
C0023448
UMLS CUI [3]
C0392920
UMLS CUI [4,1]
C1135626
UMLS CUI [4,2]
C0205217
UMLS CUI [5]
C1742845
UMLS CUI [6,1]
C1742845
UMLS CUI [6,2]
C0205419
3. female patients of childbearing potential (i.e. no hysterectomy, no loss of menses for 12 consecutive months), must be willing to use contraception.
Description

Childbearing Potential Contraceptive methods | Hysterectomy | Menstruation absent Month Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0020699
UMLS CUI [3,1]
C0497456
UMLS CUI [3,2]
C0439231
UMLS CUI [3,3]
C1265611
4. negative pregnancy test in female patients.
Description

Gender Pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0427780
5. patients must be enrolled within 6 weeks of starting induction chemotherapy.
Description

Enrollment | Induction Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1516879
UMLS CUI [2]
C3179010
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. hypocalcemia of less than 8.4 (corrected to account for the albumin level, [see appendix e for formula])
Description

Hypocalcemia | Albumin level

Data type

boolean

Alias
UMLS CUI [1]
C0020598
UMLS CUI [2]
C0428519
2. hypersensitivity to risedronate or other bisphosphonates
Description

Hypersensitivity Risedronate | Hypersensitivity Diphosphonates

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0246719
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0012544
3. inability to sit or stand upright for at least 30 minutes
Description

Unable to sit up Minute Quantity | unable to stand erect Minute Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0560836
UMLS CUI [1,2]
C0439232
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C2128578
UMLS CUI [2,2]
C0439232
UMLS CUI [2,3]
C1265611
4. bone density t-score of -2.5 s.d or less.
Description

Bone Density T score

Data type

boolean

Alias
UMLS CUI [1,1]
C0005938
UMLS CUI [1,2]
C3854607
5. renal insufficiency (calculated creatinine clearance <30cc/min,[see appendix f for formula])
Description

Renal Insufficiency | Estimation of creatinine clearance by Cockcroft-Gault formula

Data type

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C2711451
6. patients with a 25-hydroxyvitamin d concentration of less than 20 ng/ml and evidence of osteomalacia (low ionized calcium and high intact pth).
Description

25-Hydroxyvitamin D Measurement | Osteomalacia Evidence of | Calcium ionised decreased | Parathyroid hormone concentration above normal range

Data type

boolean

Alias
UMLS CUI [1]
C2984945
UMLS CUI [2,1]
C0029442
UMLS CUI [2,2]
C0332120
UMLS CUI [3]
C0855662
UMLS CUI [4]
C0748089
7. concomitant use of bisphosphonates, calcitonin, anabolic steroids, or fluoride.
Description

Diphosphonates | Calcitonin | Anabolic steroids | Fluorides

Data type

boolean

Alias
UMLS CUI [1]
C0012544
UMLS CUI [2]
C0006668
UMLS CUI [3]
C0002845
UMLS CUI [4]
C0016327
8. corrected calcium above 10.2, due to a cause not related to leukemia/lymphoma (i.e. hyperparathyroidism, multiple myeloma).
Description

Corrected serum calcium level | Cause Related lymphoma; leukemia | Hyperparathyroidism | Multiple Myeloma

Data type

boolean

Alias
UMLS CUI [1]
C1261202
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C1402819
UMLS CUI [3]
C0020502
UMLS CUI [4]
C0026764
Back to the top of the page

Similar models

Eligibility Leukemia NCT00452439

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00452439
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. age greater than or equal to 18 years
boolean
C0001779 (UMLS CUI [1])
Acute lymphocytic leukemia | Lymphoid leukemia | Chemotherapy | Berlin-Frankfort-Munster protocol Increased | hyperCVAD protocol | hyperCVAD protocol Variant
Item
2. newly diagnosed all or ll receiving chemotherapy with augmented bfm, hyper-cvad or any variant of hyper-cvad.
boolean
C0023449 (UMLS CUI [1])
C0023448 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1135626 (UMLS CUI [4,1])
C0205217 (UMLS CUI [4,2])
C1742845 (UMLS CUI [5])
C1742845 (UMLS CUI [6,1])
C0205419 (UMLS CUI [6,2])
Childbearing Potential Contraceptive methods | Hysterectomy | Menstruation absent Month Quantity
Item
3. female patients of childbearing potential (i.e. no hysterectomy, no loss of menses for 12 consecutive months), must be willing to use contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0020699 (UMLS CUI [2])
C0497456 (UMLS CUI [3,1])
C0439231 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Gender Pregnancy test negative
Item
4. negative pregnancy test in female patients.
boolean
C0079399 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Enrollment | Induction Chemotherapy
Item
5. patients must be enrolled within 6 weeks of starting induction chemotherapy.
boolean
C1516879 (UMLS CUI [1])
C3179010 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypocalcemia | Albumin level
Item
1. hypocalcemia of less than 8.4 (corrected to account for the albumin level, [see appendix e for formula])
boolean
C0020598 (UMLS CUI [1])
C0428519 (UMLS CUI [2])
Hypersensitivity Risedronate | Hypersensitivity Diphosphonates
Item
2. hypersensitivity to risedronate or other bisphosphonates
boolean
C0020517 (UMLS CUI [1,1])
C0246719 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0012544 (UMLS CUI [2,2])
Unable to sit up Minute Quantity | unable to stand erect Minute Quantity
Item
3. inability to sit or stand upright for at least 30 minutes
boolean
C0560836 (UMLS CUI [1,1])
C0439232 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C2128578 (UMLS CUI [2,1])
C0439232 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Bone Density T score
Item
4. bone density t-score of -2.5 s.d or less.
boolean
C0005938 (UMLS CUI [1,1])
C3854607 (UMLS CUI [1,2])
Renal Insufficiency | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
5. renal insufficiency (calculated creatinine clearance <30cc/min,[see appendix f for formula])
boolean
C1565489 (UMLS CUI [1])
C2711451 (UMLS CUI [2])
25-Hydroxyvitamin D Measurement | Osteomalacia Evidence of | Calcium ionised decreased | Parathyroid hormone concentration above normal range
Item
6. patients with a 25-hydroxyvitamin d concentration of less than 20 ng/ml and evidence of osteomalacia (low ionized calcium and high intact pth).
boolean
C2984945 (UMLS CUI [1])
C0029442 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
C0855662 (UMLS CUI [3])
C0748089 (UMLS CUI [4])
Diphosphonates | Calcitonin | Anabolic steroids | Fluorides
Item
7. concomitant use of bisphosphonates, calcitonin, anabolic steroids, or fluoride.
boolean
C0012544 (UMLS CUI [1])
C0006668 (UMLS CUI [2])
C0002845 (UMLS CUI [3])
C0016327 (UMLS CUI [4])
Corrected serum calcium level | Cause Related lymphoma; leukemia | Hyperparathyroidism | Multiple Myeloma
Item
8. corrected calcium above 10.2, due to a cause not related to leukemia/lymphoma (i.e. hyperparathyroidism, multiple myeloma).
boolean
C1261202 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C1402819 (UMLS CUI [2,3])
C0020502 (UMLS CUI [3])
C0026764 (UMLS CUI [4])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial